Century Therapeutics, Inc. — Director's Dealing 2021

Jun 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2021-06-17

Reporting Person: JIMENEZ JOSEPH (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-17	Option (right to buy)	$20	A	19872	Acquired	2031-06-17	Common Stock (19872)	Direct

Footnotes

F1: The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.